AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 201 filers reported holding AXSOME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.85 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,963 | -97.5% | 96,684 | +1676.0% | 0.05% | +1533.3% |
Q3 2022 | $243,000 | -49.5% | 5,444 | -53.2% | 0.00% | -50.0% |
Q1 2022 | $481,000 | -84.1% | 11,627 | -68.4% | 0.01% | -92.4% |
Q2 2020 | $3,028,000 | +441.7% | 36,804 | +69.6% | 0.08% | +259.1% |
Q2 2019 | $559,000 | -37.4% | 21,703 | -65.4% | 0.02% | -67.2% |
Q1 2019 | $893,000 | – | 62,772 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |